Lawyers for talcum powder plaintiffs argued in federal appeals court on Monday to reverse a bankruptcy court’s decision that halted nearly 40,000 lawsuits against Johnson & Johnson.

Jeffrey Lamken, of MoloLamken in Washington, D.C., representing the Official Committee of Talc Claimants, said the Chapter 11 case of the subsidiary, LTL Management, had no valid purpose because it violated core principles of bankruptcy law—most notably, that creditors, like his clients, who claim Johnson & Johnson’s baby powder caused cancer, should get priority over equity holders.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]